Literature DB >> 22861127

Adult worm-specific IgE/IgG4 balance is associated with low infection levels of Schistosoma mansoni in an endemic area.

J P Figueiredo1, R R Oliveira, L S Cardoso, K C Barnes, A V Grant, E M Carvalho, M I Araujo.   

Abstract

Field studies have suggested an immune-mediated mechanism associated with resistance to Schistosoma mansoni infection. Overall, levels of specific IgE have been correlated with resistance to infection, whereas levels of IgG4 have been associated with susceptibility. This study aimed to evaluate serum levels of soluble adult worm antigen preparation (SWAP)-specific IgE and IgG4 in relation to current infection in a large casuistic of individuals living in an endemic area of schistosomiasis in Bahia, Brazil. The prevalence of S. mansoni infection was 37·7% and the mean parasite burden was 55·4 (0-2100) epg/faeces. There was no significant difference in the levels of SWAP-specific IgE in individuals with different parasite burden, whereas high producers of parasite-specific IgG4 presented higher parasite burden when compared to low IgG4 producers. Additionally, S. mansoni parasite load was positively correlated with the levels of specific IgG4 or total IgE. No significant correlation was observed between parasite burden and SWAP-specific IgE. Nevertheless, SWAP-specific IgE/IgG4 ratio was higher in uninfected or lightly infected individuals (1-99 epg/faeces) than in heavily infected ones (≥400 epg/feces). These findings highlight the important role of IgE/IgG4 ratio in the resistance to infection, which could be useful for further studies in schistosomiasis vaccine candidates.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22861127     DOI: 10.1111/pim.12001

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  11 in total

1.  Development of a specimen-sparing multichannel bead assay to detect antiparasite IgG4 for the diagnosis of Schistosoma and Wuchereria infections on the coast of Kenya.

Authors:  Adam S DuVall; Jessica K Fairley; Laura Sutherland; Amaya L Bustinduy; Peter L Mungai; Eric M Muchiri; Indu Malhotra; Uriel Kitron; Charles H King
Journal:  Am J Trop Med Hyg       Date:  2014-02-10       Impact factor: 2.345

2.  The soluble worm antigens-specific antibodies used as biomarkers of Schistosoma japonicum in a low prevalence and intensity endemic area of Hubei, China.

Authors:  Jianping Zhao; Xiaoping Chen; Xin Long; Nicholas Rafaels; Monica Campbell; Huifang Liang; Bixiang Zhang; Kathleen C Barnes; Robert G Hamilton; Qian Chen
Journal:  Acta Trop       Date:  2019-04-13       Impact factor: 3.222

3.  Association of Schistosoma mansoni-specific IgG and IgE antibody production and clinical schistosomiasis status in a rural area of Minas Gerais, Brazil.

Authors:  Deborah Negrão-Corrêa; Juliana F Fittipaldi; José Roberto Lambertucci; Mauro Martins Teixeira; Carlos Maurício de Figueiredo Antunes; Mariângela Carneiro
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

Review 4.  Induction of protective immune responses against schistosomiasis using functionally active cysteine peptidases.

Authors:  Rashika El Ridi; Hatem Tallima; John P Dalton; Sheila Donnelly
Journal:  Front Genet       Date:  2014-05-08       Impact factor: 4.599

5.  Use of humanised rat basophilic leukaemia cell line RS-ATL8 for the assessment of allergenicity of Schistosoma mansoni proteins.

Authors:  Daniel Wan; Fernanda Ludolf; Daniel G W Alanine; Owen Stretton; Eman Ali Ali; Nafal Al-Barwary; Xiaowei Wang; Michael J Doenhoff; Adriano Mari; Colin M Fitzsimmons; David W Dunne; Ryosuke Nakamura; Guilherme C Oliveira; Marcos J C Alcocer; Franco H Falcone
Journal:  PLoS Negl Trop Dis       Date:  2014-09-25

6.  Immune Profile of Honduran Schoolchildren with Intestinal Parasites: The Skewed Response against Geohelminths.

Authors:  José Antonio Gabrie; María Mercedes Rueda; Carol Anahelka Rodríguez; Maritza Canales; Ana Lourdes Sanchez
Journal:  J Parasitol Res       Date:  2016-11-01

7.  Cysteine peptidases as schistosomiasis vaccines with inbuilt adjuvanticity.

Authors:  Rashika El Ridi; Hatem Tallima; Sahar Selim; Sheila Donnelly; Sophie Cotton; Bibiana Gonzales Santana; John P Dalton
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

Review 8.  Host determinants of reinfection with schistosomes in humans: a systematic review and meta-analysis.

Authors:  Evaristus Chibunna Mbanefo; Nguyen Tien Huy; Anita Akpeedje Wadagni; Christine Ifeoma Eneanya; Obioma Nwaorgu; Kenji Hirayama
Journal:  PLoS Negl Trop Dis       Date:  2014-09-11

9.  Is arachidonic acid an endoschistosomicide?

Authors:  Violette Said Hanna; Azza Gawish; Marwa Abou El-Dahab; Hatem Tallima; Rashika El Ridi
Journal:  J Adv Res       Date:  2018-01-10       Impact factor: 10.479

10.  Effect of four rounds of annual school-wide mass praziquantel treatment for schistosoma mansoni control on schistosome-specific immune responses.

Authors:  E M Ndombi; B Abudho; N Kittur; J M Carter; H Korir; D K Riner; H Ochanda; Y-M Lee; W E Secor; D M Karanja; D G Colley
Journal:  Parasite Immunol       Date:  2018-04-29       Impact factor: 2.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.